The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes.
Authors:
- 1 April 1993
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (7) , 2769-2773
Abstract
Mononuclear phagocytes infected with human immunodeficiency virus 1 (HIV-1) produce soluble factors that kill neurons in culture. To define the molecular events that lead to neuron killing, HIV-1 proteins were tested for the ability to trigger release of neurotoxins from human monocytes and lymphocytes. None of the recombinant-derived HIV-1 proteins examined (reverse transcriptase, protease, gag, nef, or gp120) were directly neurotoxic at concentrations from 100 pM to 10 nM. The envelope glycoprotein gp120 did, however, stimulate both isolated human blood monocytes and the monocytoid line THP-1 (but not lymphocytes or the lymphoid cell line H9) to discharge neurotoxic factors. These toxins consisted of heat-stable, protease-resistant molecules (< 500 Da) that copurified with neurotoxins from HIV-1-infected THP-1 cells and were blocked by antagonists to N-methyl-D-aspartate receptors. Release of neurotoxins through gp120 stimulation involved monocytoid CD4 receptors because toxin production could be inhibited either by a monoclonal antibody to the CD4-binding region of gp120 or by soluble CD4 receptors. Alternatively, production of neuron-killing factors could be induced with a peptide from the CD4-binding region of gp120. These data show that the HIV-1 envelope glycoprotein alone can stimulate neurotoxin release by binding to CD4 receptors of mononuclear phagocytes. Such neurotoxic factors may, in turn, contribute to the central nervous system dysfunction associated with HIV-1 by acting on neurons through N-methyl-D-aspartate receptors.Keywords
This publication has 33 references indexed in Scilit:
- Identification of the Envelope V3 Loop as the Primary Determinant of Cell Tropism in HIV-1Science, 1991
- Neocortical damage during HIV infectionAnnals of Neurology, 1991
- Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndromeAnnals of Neurology, 1989
- Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptideNature, 1988
- Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptorCell, 1987
- The AIDS dementia complex: I. Clinical featuresAnnals of Neurology, 1986
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Purification of thromboxane synthetase and evidence of two distinct mechanisms for the formation of 12-l-hydroxy-5,8,10-heptadecatrienoic acid by porcine lung microsomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- The Macrophage as an Effector CellNew England Journal of Medicine, 1980